Fulgent Genetics (FLGT)
(Delayed Data from NSDQ)
$17.31 USD
-0.48 (-2.70%)
Updated Nov 15, 2024 04:00 PM ET
After-Market: $17.32 +0.01 (0.06%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$17.31 USD
-0.48 (-2.70%)
Updated Nov 15, 2024 04:00 PM ET
After-Market: $17.32 +0.01 (0.06%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Zacks News
FULGENT GENETIC (FLGT) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
FULGENT GENETIC (FLGT) delivered earnings and revenue surprises of 1600.00% and 18.91%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
FULGENT GENETIC (FLGT) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
FULGENT GENETIC (FLGT) delivered earnings and revenue surprises of 0.00% and 0.82%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Will FULGENT GENETIC (FLGT) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
FULGENT GENETIC (FLGT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FULGENT GENETIC (FLGT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
FULGENT GENETIC (FLGT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in Store for Fulgent Genetics (FLGT) Q4 Earnings?
by Zacks Equity Research
Fulgent Genetics' (FLGT) fourth-quarter 2019 earnings are likely to reflect top-line growth and elevated test volumes.
5 Top-Ranked Stocks Beating the Market at Midway Q1
by Sweta Killa
Better-than-expected earnings, positive development in the U.S.-China trade relationship, China stimulus measures, easing policies and slew of upbeat economic data buoyed the stocks.
Zacks.com featured highlights include: AQN, IDN, FLGT and SMED
by Zacks Equity Research
Zacks.com featured highlights include: AQN, IDN, FLGT and SMED
4 Breakout Stocks for Explosive Returns
by Nitish Marwah
Picking breakout stocks is one of the most favored methods for those utilizing an active investing approach since this strategy offers the scope of superlative returns.
Is FULGENT GENETIC (FLGT) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (FLGT) Outperforming Other Medical Stocks This Year?
The Zacks Analyst Blog Highlights: EverQuote, Cassava Sciences, Fulgent Genetics, Teekay Tankers and Cue Biopharma
by Zacks Equity Research
The Zacks Analyst Blog Highlights: EverQuote, Cassava Sciences, Fulgent Genetics, Teekay Tankers and Cue Biopharma
5 Stocks to Soar in 2020 After Solid Gains in 2019
by Zacks Equity Research
U.S. stocks rallied to attained fresh all-time highs in 2019, as the momentum continued in 2020. Here are five stocks that are poised to grow.
The Zacks Analyst Blog Highlights: Fulgent Genetics, Teekay Tankers, Ultra Clean, Boot Barn and Sonic Automotive
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Fulgent Genetics, Teekay Tankers, Ultra Clean, Boot Barn and Sonic Automotive
2019 Hits a Purple Patch So Far: Check the Movers & Shakers
by Zacks Equity Research
Buy these five bets that reap solid returns from the Wall Street's rally in 2019 and are poised to yield high in the coming year.
Zacks.com featured highlights include: Brinker International, Sonic Automotive, Fulgent Genetics, Hewlett Packard and Regeneron Pharmaceuticals
by Zacks Equity Research
Zacks.com featured highlights include: Brinker International, Sonic Automotive, Fulgent Genetics, Hewlett Packard and Regeneron Pharmaceuticals
Buy These 5 Top-Ranked Stocks With Upgraded Broker Ratings
by Swayta Shah
By following broker rating upgrades, an investor can easily find attractive stocks.
FULGENT GENETIC (FLGT) Is Up 68.12% in One Week: What You Should Know
by Zacks Equity Research
Does FULGENT GENETIC (FLGT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Find Strong Buy Stocks with this Filtered Zacks Rank 5 Stock Screener
by Benjamin Rains
Zacks Rank #1 (Strong Buy) stocks outperform the market in good and bad times. Today, we show investors how to add two simple filters to narrow down the number of stocks and try to increase performance...
Top Ranked Momentum Stocks to Buy for November 11th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, November 11th
Surging Earnings Estimates Signal Upside for FULGENT GENETIC (FLGT) Stock
by Zacks Equity Research
FULGENT GENETIC (FLGT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Fulgent Genetics, Inc. (FLGT) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Fulgent Genetics, Inc. (FLGT).
FULGENT GENETIC (FLGT) Reports Next Week: What Awaits?
by Zacks Equity Research
FULGENT GENETIC (FLGT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FULGENT GENETIC (FLGT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
FULGENT GENETIC (FLGT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FULGENT GENETIC (FLGT) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
FULGENT GENETIC (FLGT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Fulgent Genetics Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Fulgent Genetics has been struggling lately, but the selling pressure may be coming to an end soon.
FULGENT GENETIC (FLGT) Reports Break-Even Earnings for Q3
by Zacks Equity Research
FULGENT GENETIC (FLGT) delivered earnings and revenue surprises of 100.00% and 1.72%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?